In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

NEED HELP?

Read the Frequently Asked Questions for a better use

READ MORE

 

Refine your search
Sponsor

ESC Congress 365

Your free access to ESC Congress content all year long 

The online library to view thousands of videos, slides, abstracts and reports from the world's largest cardiovascular congress – anytime & without subscription!

To make the most of it watch the tutorial video or check out the FAQ!

 

 

ESC Congress 365 only features abstracts, slides, reports and/or videos for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

presentations found.

SPONSORED RESOURCES

Presentations below are part of sessions supported by Bayer.

Bayer
Abstract Slides/e-posters Video Report Interview
 
Questions - From acute PE to CTEPH: related diseases, different solutions.
Presenter: M Delcroix (Leuven,BE), H A Ghofrani (Giessen,DE), S V Konstantinides (Mainz,DE), A Torbicki (Otwock,PL)
2014
more
 
Oral anticoagulation in patients undergoing cardioversion: new horizons open up.
Presenter: M D Ezekowitz (Villanova,US)
2014
more
 
more
 
Panel discussion and audience Q&A - Perception or reality? Time to re-evaluate the safety of aspirin.
2014
more
 
Practical issues for use of oral factor Xa inhibition following ACS: risk stratification, patient selection,timing of therapy, bleeding risk reduction, stented patients and long-term management.
Presenter: P G Steg (Paris,FR)
2014
more
 
Chairman's welcome and introduction - From acute PE to CTEPH: related diseases, different solutions.
Presenter: M A Gomez Sanchez (Madrid,ES)
2014
more
 
Chairperson's summary and close - Rivaroxaban in cardiology.
Presenter: A J Camm (London,GB)
2014
more
 
Anticoagulant use in patients with atrial fibrillation: daily management challenges.
Presenter: E Hylek (Boston,US)
2014
more
 
Using the right strategies for managing oral anticoagulation: points you need to know.
Presenter: A J Camm (London,GB)
2014
more
 
The role of factor Xa inhibition in ACS patients with and without atrial fibrillation: safe and effective use of factor Xa inhibition within the framework of triple antithrombotic therapy.
Presenter: D L Bhatt (Newton,US)
2014
more

The scientific Programme has been prepared by the Congress Programme Committee in close collaboration with the ESC Working Groups, ESC Associations and the ESC Councils.

 

Bayer Bayer HealthCare